Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Syngene International Limited
  6. News
  7. Most relevant
    539268   INE398R01022

SYNGENE INTERNATIONAL LIMITED

(539268)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SYNGENE INTERNATIONAL LIMITED
07/20SYNGENE INTERNATIONAL : Consolidated Net Profit Climbs in Fiscal Q1
MT
07/20Syngene International Limited Announces Resignation of John M M Shaw from the Board of ..
CI
07/20Syngene International Limited Reports Earnings Results for the First Quarter Ended June..
CI
06/22Syngene International Limited Appoints Dr. Kush Parmar as an Additional Director (Indep..
CI
05/26DYADIC INTERNATIONAL : Syngene to Join Forces for COVID-19 Vaccine Production
MT
05/26SYNGENE INTERNATIONAL : Dyadic announces development of COVID-19 Vaccine in India
AQ
05/26Dyadic International, Inc. Enters into Collaboration with Syngene International Limited
CI
04/28BIOCON : Syngene targets delivering 500,000 vials of remdesivir in India as COVID-19 surge..
RE
04/28SYNGENE INTERNATIONAL : Posts Higher Profit in January-March
MT
04/27Syngene International Limited Reports Earnings Results for the Fourth Quarter Ended Mar..
CI
04/27Syngene International Limited Announces No Dividend for the Financial Year 2020-2021
CI
04/01SYNGENE INTERNATIONAL : Picks Minority Stake in HR Kaveri
MT
01/20Syngene International Limited Reports Earnings Results for the Third Quarter Ended Dece..
CI
2020Syngene International Limited to Undertake Scaled Manufacture Feasibility Studies Prior..
CI
2020SYNGENE INTERNATIONAL : Arm Collaborates with US Firm for Therapeutic Discovery Projects
MT
2020Syngene International and Deerfield Discovery and Development Signs 5-Year Strategic Co..
CI
2020Syngene International Limited Reports Earnings Results for the Second Quarter Ended Sep..
CI
2020BIOCON : Foundation Signs MoU with Bangalore Metro to Contribute Towards Building Metro St..
AQ
2020Himedia Laboratories, and Syngene International Collaborates to Manufacture ELISafe 19T..
CI
2020Zydus Cadila launches India's cheapest remdesivir version at $37 per vial
RE
2020Syngene International Limited Provides Earnings Guidance for the Year 2021
CI
2020Syngene International Limited Reports Earnings Results for the First Quarter Ended June..
CI
2020Syngene International Ltd. Enters into Collaboration with HiMedia Laboratories
CI
2020Syngene International Limited Provides Earnings Guidance for the First Quarter and Full..
CI
2020Syngene International Limited Reports Earnings Results for the Fourth Quarter Ended Mar..
CI
2020Syngene International Limited Declares No Dividend for the Financial Year 2019-2020
CI
2020Syngene International Limited Approves Retirement of Bala Manian as Independent Directo..
CI
2020Syngene International Limited Announces That Jonathan Hunt Assumes the Role of Managing..
CI
2020Syngene International Limited Intimation on Temporary Suspension of Research Activities..
CI
2020Syngene International Limited Announces Intimation of Commencement of Operations at Man..
CI
2020Syngene International Limited Announces Management Changes
CI
2020Syngene International Limited Reports Earnings Results for the Third Quarter Ended Dece..
CI
2019Syngene International Limited Appoints Sibaji Biswas as Chief Financial Officer and Mem..
CI
2019Syngene International Limited Reports Earnings Results for the Second Quarter Ended Sep..
CI
2019Syngene International Limited Announces Appointment of Carl Decicco as Additional Indep..
CI
2019Syngene International Limited Reports Earnings Results for the First Quarter Ended June..
CI
2019Syngene International Limited Announces Opening of New Hyderabad Research Centre
CI
2019Syngene International Limited Announces the Appointment Of Priyadarshini Mahapatra as C..
CI
2019Syngene International Limited Announces the Appointment of Mahesh Bhalgat as Chief Oper..
CI
2019Syngene International Limited Recommends Final Dividend for the Fiscal Year 2019, Payab..
CI
2019Syngene International Limited Announces Executive Changes
CI
2019Syngene International Ltd. Reports Earnings Results for the Fourth Quarter Ended March ..
CI
2019Syngene International Limited Recommends Final Dividend for the Financial Year Ended Ma..
CI
2019Syngene International Ltd. Announces the Opening of its Centre for Advanced Protein Stu..
CI
2019Syngene International Ltd. Reports Earnings Results for the Third Quarter Ended Decembe..
CI
2018Syngene International Limited Announces Unaudited Standalone and Consolidated Earnings ..
CI
2018Syngene International Announces Resignation of Manoj Nerurkar as Chief Operating Office..
CI
2018Syngene International Limited Reports Unaudited Consolidated and Standalone Earnings Re..
CI
2018Syngene International Ltd. Announces the Expansion of the Scope of its R&D Collaboratio..
CI
2018Syngene International Limited Proposes Final Dividend for the Financial Year Ended Marc..
CI
2018Artelo Biosciences, Inc. Enters into Global R&D Partnership with Syngene International ..
CI
2018Syngene International Limited Recommends Final Dividend for the Year Ended March 31, 20..
CI
2018Syngene International Limited Reports Audited Standalone and Consolidated Earnings Resu..
CI
2018Syngene International Limited Announces R&D Agreement with GSK
CI
2018Syngene International Ltd Announces Executive Appointments
CI
2018Syngene International Limited Announces Financial Results for the Third Quarter and Nin..
CI
2018Syngene International Ltd. Reports Revenue Results for the Third Quarter of Fiscal 2018
CI
2017Bristol-Myers Squibb and Syngene International Limited Expand Ongoing Research Collabor..
CI
2017Syngene International Limited Announces Unaudited Earnings Results for the Quarter and ..
CI
2017Syngene International Limited Approves Final Dividend for the Financial Year Ended Marc..
CI
2017Syngene International Ltd. Reports Unaudited Earnings Results for the First Quarter End..
CI
2017Syngene International Limited Approves the Appointment of Vinita Bali as Additional Dir..
CI
2017Syngene International Limited Appoints Sebi Chacko as Chief People Officer
CI
2017Syngene International Limited Recommends Final Dividend for the Financial Year Ended Ma..
CI
2017Syngene International Limited Announces Board Changes
CI
2017Syngene International Limited Announces Audited Consolidated Financial Results for the ..
CI
2017Syngene International Ltd. Recommends Final Dividend for the Year Ended March 31, 2017,..
CI
2017Syngene International Limited Appoints Vijay Kuchroo as Non-Executive, Independent Dire..
CI
2017Syngene International Ltd. Announces Unaudited Standalone Earnings Results for the Thir..
CI
2016Syngene International Ltd. Reports Unaudited Standalone Earnings Results for the Second..
CI
2016Syngene International Ltd. acquired systems biology, Heptox and pharma bioinformatics s..
CI
2016SYNGENE INTERNATIONAL LTD.(BSE : 539268) added to S&P Global BMI Index
CI
2016Syngene International Ltd. Announces the Establishment of Multi-Disciplinary Drug Disco..
CI
2016Syngene International Ltd. Reports Unaudited Standalone Earnings Results for the First ..
CI
2016Syngene International Ltd. Proposes Final Dividend for the Year Ended March 31, 2016
CI
1  2Next
Upcoming event on SYNGENE INTERNATIONAL LIMITED